Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer.
Ahn MJ, Yang JC, Liang J, Kang JH, Xiu Q, Chen YM, Blair JM, Peng G, Linn C, Orlando M. Ahn MJ, et al. Among authors: linn c. Lung Cancer. 2012 Aug;77(2):346-52. doi: 10.1016/j.lungcan.2012.03.011. Epub 2012 Apr 23. Lung Cancer. 2012. PMID: 22534669 Clinical Trial.
Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial.
Monk BJ, Colombo N, Oza AM, Fujiwara K, Birrer MJ, Randall L, Poddubskaya EV, Scambia G, Shparyk YV, Lim MC, Bhoola SM, Sohn J, Yonemori K, Stewart RA, Zhang X, Perkins Smith J, Linn C, Ledermann JA. Monk BJ, et al. Among authors: linn c. Lancet Oncol. 2021 Sep;22(9):1275-1289. doi: 10.1016/S1470-2045(21)00342-9. Epub 2021 Aug 4. Lancet Oncol. 2021. PMID: 34363762 Clinical Trial.
Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2- advanced breast cancer in Chinese women.
Xu B, Li H, Zhang Q, Sun W, Yu Y, Li W, Wang S, Liao N, Shen P, Liu Y, Huang Y, Linn C, Zhao H, Jiang J, Wang D. Xu B, et al. Among authors: linn c. Cancer Chemother Pharmacol. 2021 Jul;88(1):131-141. doi: 10.1007/s00280-021-04263-9. Epub 2021 Apr 9. Cancer Chemother Pharmacol. 2021. PMID: 33835229 Clinical Trial.
Microscopic Menaces: The Impact of Mites on Human Health.
Linn C, O'Malley A, Khatri K, Wright EM, Sebagh D, Grbić M, Kowal K, Chruszcz M. Linn C, et al. Int J Mol Sci. 2024 Mar 26;25(7):3675. doi: 10.3390/ijms25073675. Int J Mol Sci. 2024. PMID: 38612486 Free PMC article. Review.
Role of Small Molecule Ligands in IgE-Mediated Allergy.
Khatri K, O'Malley A, Linn C, Kowal K, Chruszcz M. Khatri K, et al. Among authors: linn c. Curr Allergy Asthma Rep. 2023 Sep;23(9):497-508. doi: 10.1007/s11882-023-01100-2. Epub 2023 Jun 23. Curr Allergy Asthma Rep. 2023. PMID: 37351723 Review.
Early career researchers benefit from inclusive, diverse and international collaborations: Changing how academic institutions utilize the seminar series.
Febria CM, Kashian DR, Bertrand KRT, Dabney B, Day M, Dugdale M, Ekhator KO, Esparra-Escalera HJ, Graham R, Harshaw K, Hunt DS, Knorr S, Lewandowski K, Linn C, Lucas A, Mundle SOC, Raoufi G, Salter C, Siddiqua Z, Tyagi S, Wallen MM. Febria CM, et al. Among authors: linn c. J Great Lakes Res. 2022 Jun;48(3):849-855. doi: 10.1016/j.jglr.2022.03.017. Epub 2022 Apr 15. J Great Lakes Res. 2022. PMID: 36591538 Free PMC article.
257 results